InvestorsHub Logo
Followers 833
Posts 119832
Boards Moderated 17
Alias Born 09/05/2002

Re: NY1972 post# 1215

Tuesday, 11/24/2015 9:53:29 AM

Tuesday, November 24, 2015 9:53:29 AM

Post# of 3007
NVS obtained its cyclophilin inhibitor from Debiopharm, who reclaimed the rights to the compound when NVS pulled out.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News